Home>News

Anhui Lifeon Pharmaceutical listed on Shenzhen Stock Exchange

Updated: 2020-12-17

|

(hefeihightech.chinadaily.com.cn)

Print

微信图片_20201217132521.jpg

Anhui Lifeon Pharmaceutical celebrates its listing on the Shenzhen Stock Exchange on Dec 15. [Photo/WeChat account: hefeigaoxinfabu]

Anhui Lifeon Pharmaceutical -- a Hefei-based innovative pharmaceutical company which owns more than 30 patents for inventions -- was listed on the Shenzhen Stock Exchange on Dec 15, according to a company spokesman.

It is the first company in the Hefei National High-tech Industry Development Zone to be listed on the Shenzhen Stock Exchange this year and the fifth company in the zone to be floated in 2020.

Established in 2002, the company is engaged in the research and development, production and sales of pharmaceutical preparations and materials -- as well as in wholesale and retail pharmaceuticals and medical devices. Its main products span cardiovascular drugs, digestive system drugs, external skin drugs, endocrine system drugs and other fields.

The company issued 23.16 million shares at an issue price of 23.13 yuan ($3.54) per share. The total amount of funds to be raised by the issuer is expected to be 535.69 million yuan.

微信图片_20201217132539.jpg

Anhui Lifeon Pharmaceutical is located in the Hefei National High-tech Industry Development Zone. [Photo/WeChat account: hefeigaoxinfabu]